Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| FOSTER L B COFSTR · Entity 5689 | Senior VP & CFO | February 21, 2020 | February 25, 2020 |
| MEDIFAST INCMED · Entity 6587 | Chief Financial Officer | March 13, 2026 | March 27, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
FOSTER L B CO
Report date February 21, 2020 · Filed February 25, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 21,964 |
Ending reported balance
After 2020-02-22 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2020-02-21 · Tax withholding · Disposed 759 · Balance 13,817 Row 2 · 2020-02-22 · Tax withholding · Disposed 349 · Balance 13,468 Row 3 · 2020-02-22 · Grant · Acquired 15,077 · Balance 28,545 F1: Represents performance share units which were contingent rights to receive shares of common stock based on the Issuer's performance against certain pre-established financial metrics for the 2017-2019 performance period. Row 4 · 2020-02-22 · Tax withholding · Disposed 6,581 · Balance 21,964 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents performance share units which were contingent rights to receive shares of common stock based on the Issuer's performance against certain pre-established financial metrics for the 2017-2019 performance period.
MEDIFAST INC
Report date March 13, 2026 · Filed March 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 73,033 |
Ending reported balance
After 2026-03-25 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2026-03-13 · Tax withholding · Disposed 918 · Balance 41,381 F1: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. Row 2 · 2026-03-17 · Tax withholding · Disposed 482 · Balance 40,899 F1: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. Row 3 · 2026-03-25 · Tax withholding · Disposed 3,224 · Balance 37,675 F1: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. Row 4 · 2026-03-25 · Grant · Acquired 34,344 · Balance 72,019 F2: Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Row 5 · 2026-03-25 · Grant · Acquired 1,014 · Balance 73,033 F3: Represents shares of common stock issued upon the vesting and settlement of performance stock units previously granted to the reporting person on March 17, 2023, which were earned based on achievement of performance criteria certified by the Compensation Committee on February 5, 2026. Each PSU represented a contingent right to receive one share of common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.
F2: Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F3: Represents shares of common stock issued upon the vesting and settlement of performance stock units previously granted to the reporting person on March 17, 2023, which were earned based on achievement of performance criteria certified by the Compensation Committee on February 5, 2026. Each PSU represented a contingent right to receive one share of common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 25, 2026 Filed Mar 27, 2026 21:52 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 1,014 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-021796 · wk-form4_1774648372.xml · nonDerivative · entry 5 Maloney James P. · CIK 0001715428 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,033 F3 · shares: Represents shares of common stock issued upon the vesting and settlement of performance stock units previously granted to the reporting person on March 17, 2023, which were earned based on achievement of performance criteria certified by the Compensation Committee on February 5, 2026. Each PSU represented a contingent right to receive one share of common stock. Read SEC document |
| March 25, 2026 Filed Mar 27, 2026 21:52 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 34,344 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-021796 · wk-form4_1774648372.xml · nonDerivative · entry 4 Maloney James P. · CIK 0001715428 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,019 F2 · shares: Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 25, 2026 Filed Mar 27, 2026 21:52 UTC | MEDIFAST INC MED · Entity 6587 | Tax withholdingCommon Stock | 3,224 | $9.59 | $30,918.16 |
DisclosureSEC source: 0001628280-26-021796 · wk-form4_1774648372.xml · nonDerivative · entry 3 Maloney James P. · CIK 0001715428 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,675 F1 · shares: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. F1 · price: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. Read SEC document |
| March 17, 2026 Filed Mar 27, 2026 21:52 UTC | MEDIFAST INC MED · Entity 6587 | Tax withholdingCommon Stock | 482 | $10.05 | $4,844.10 |
DisclosureSEC source: 0001628280-26-021796 · wk-form4_1774648372.xml · nonDerivative · entry 2 Maloney James P. · CIK 0001715428 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,899 F1 · shares: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. F1 · price: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. Read SEC document |
| March 13, 2026 Filed Mar 27, 2026 21:52 UTC | MEDIFAST INC MED · Entity 6587 | Tax withholdingCommon Stock | 918 | $9.62 | $8,831.16 |
DisclosureSEC source: 0001628280-26-021796 · wk-form4_1774648372.xml · nonDerivative · entry 1 Maloney James P. · CIK 0001715428 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,381 F1 · shares: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. F1 · price: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. Read SEC document |
| March 25, 2025 Filed Mar 27, 2025 22:04 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 24,161 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-015274 · wk-form4_1743113081.xml · nonDerivative · entry 1 Maloney James P. · CIK 0001715428 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,299 F1 · shares: Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 01:27 UTC | MEDIFAST INC MED · Entity 6587 | Tax withholdingCommon Stock | 438 | $14.35 | $6,285.30 |
DisclosureSEC source: 0001628280-25-013670 · wk-form4_1742347653.xml · nonDerivative · entry 3 Maloney James P. · CIK 0001715428 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,138 F1 · shares: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. F1 · price: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. Read SEC document |
| March 16, 2025 Filed Mar 19, 2025 01:27 UTC | MEDIFAST INC MED · Entity 6587 | Tax withholdingCommon Stock | 123 | $13.94 | $1,714.62 |
DisclosureSEC source: 0001628280-25-013670 · wk-form4_1742347653.xml · nonDerivative · entry 2 Maloney James P. · CIK 0001715428 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,576 F1 · shares: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. F1 · price: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. Read SEC document |
| March 13, 2025 Filed Mar 19, 2025 01:27 UTC | MEDIFAST INC MED · Entity 6587 | Tax withholdingCommon Stock | 835 | $13.87 | $11,581.45 |
DisclosureSEC source: 0001628280-25-013670 · wk-form4_1742347653.xml · nonDerivative · entry 1 Maloney James P. · CIK 0001715428 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,699 F1 · shares: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. F1 · price: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 22:16 UTC | MEDIFAST INC MED · Entity 6587 | Tax withholdingCommon Stock | 424 | $36.61 | $15,522.64 |
DisclosureSEC source: 0001628280-24-011975 · wk-form4_1710886551.xml · nonDerivative · entry 3 Maloney James P. · CIK 0001715428 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,534 F1 · shares: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. F1 · price: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 22:16 UTC | MEDIFAST INC MED · Entity 6587 | Tax withholdingCommon Stock | 119 | $36.61 | $4,356.59 |
DisclosureSEC source: 0001628280-24-011975 · wk-form4_1710886551.xml · nonDerivative · entry 2 Maloney James P. · CIK 0001715428 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,958 F1 · shares: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. F1 · price: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 22:16 UTC | MEDIFAST INC MED · Entity 6587 | Tax withholdingCommon Stock | 73 | $36.61 | $2,672.53 |
DisclosureSEC source: 0001628280-24-011975 · wk-form4_1710886551.xml · nonDerivative · entry 1 Maloney James P. · CIK 0001715428 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,077 F1 · shares: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. F1 · price: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. Read SEC document |
| March 13, 2024 Filed Mar 15, 2024 21:33 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 8,718 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-011544 · wk-form4_1710538400.xml · nonDerivative · entry 1 Maloney James P. · CIK 0001715428 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,150 F1 · shares: Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 22:51 UTC | MEDIFAST INC MED · Entity 6587 | Tax withholdingCommon Stock | 648 | $52.68 | $34,136.64 |
DisclosureSEC source: 0001628280-24-005405 · wk-form4_1708123857.xml · nonDerivative · entry 2 Maloney James P. · CIK 0001715428 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,432 Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 22:51 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 2,328 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-005405 · wk-form4_1708123857.xml · nonDerivative · entry 1 Maloney James P. · CIK 0001715428 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,080 F1 · price: 1,164 Performance Stock Units were granted on March 17, 2021, and vested on December 31, 2023 and converted into common stock on a two-for-one basis due to the achievement of certain performance factors. The Compensation Committee of the Medifast Board of Directors approved the performance factors on February 14, 2024 and the shares were released on February 14, 2024. Read SEC document |
| July 20, 2023 Filed Jul 25, 2023 01:24 UTC | MEDIFAST INC MED · Entity 6587 | Tax withholdingCommon Stock | 1,027 | $94.50 | $97,051.50 |
DisclosureSEC source: 0001628280-23-025514 · wk-form4_1690248243.xml · nonDerivative · entry 3 Maloney James P. · CIK 0001715428 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,752 Read SEC document |
| July 20, 2023 Filed Jul 25, 2023 01:24 UTC | MEDIFAST INC MED · Entity 6587 | Exercise / conversionCommon Stock | 3,574 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-025514 · wk-form4_1690248243.xml · nonDerivative · entry 2 Maloney James P. · CIK 0001715428 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,779 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: 1,787 Performance Stock Units were granted on July 20, 2020, and vested on July 20, 2023 and converted into common stock on a two-for-one basis due to the achievement of certain performance factors. Read SEC document |
| July 20, 2023 Filed Jul 25, 2023 01:24 UTC | MEDIFAST INC MED · Entity 6587 | Tax withholdingCommon Stock | 115 | $94.50 | $10,867.50 |
DisclosureSEC source: 0001628280-23-025514 · wk-form4_1690248243.xml · nonDerivative · entry 1 Maloney James P. · CIK 0001715428 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,205 Read SEC document |
| March 17, 2023 Filed May 1, 2023 12:48 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 4,574 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-014351 · wf-form4_168294527313368.xml · nonDerivative · entry 3 Maloney James P. · CIK 0001715428 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,320 F1 · shares: Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 17, 2023 Filed May 1, 2023 12:48 UTC | MEDIFAST INC MED · Entity 6587 | Tax withholdingCommon Stock | 75 | $102.75 | $7,706.25 |
DisclosureSEC source: 0001628280-23-014351 · wf-form4_168294527313368.xml · nonDerivative · entry 2 Maloney James P. · CIK 0001715428 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,746 Read SEC document |
| March 16, 2023 Filed May 1, 2023 12:48 UTC | MEDIFAST INC MED · Entity 6587 | Tax withholdingCommon Stock | 123 | $104.46 | $12,848.58 |
DisclosureSEC source: 0001628280-23-014351 · wf-form4_168294527313368.xml · nonDerivative · entry 1 Maloney James P. · CIK 0001715428 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,821 Read SEC document |
| July 20, 2022 Filed Jul 22, 2022 22:57 UTC | MEDIFAST INC MED · Entity 6587 | Tax withholdingCommon Stock | 115 | $174.44 | $20,060.60 |
DisclosureSEC source: 0001104659-22-082119 · tm2221679-1_4seq1.xml · nonDerivative · entry 1 Maloney James P. · CIK 0001715428 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,944 Read SEC document |
| March 17, 2022 Filed Mar 21, 2022 22:58 UTC | MEDIFAST INC MED · Entity 6587 | Tax withholdingCommon Stock | 75 | $180.52 | $13,539.00 |
DisclosureSEC source: 0001104659-22-036229 · tm2210070-3_4seq1.xml · nonDerivative · entry 2 Maloney James P. · CIK 0001715428 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,059 Read SEC document |
| March 16, 2022 Filed Mar 21, 2022 22:58 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 1,281 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-036229 · tm2210070-3_4seq1.xml · nonDerivative · entry 1 Maloney James P. · CIK 0001715428 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,134 F1 · shares: Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock Read SEC document |
| July 20, 2021 Filed Jul 23, 2021 01:18 UTC | MEDIFAST INC MED · Entity 6587 | Tax withholdingCommon Stock | 115 | $277.00 | $31,855.00 |
DisclosureSEC source: 0001104659-21-095090 · tm2123073-1_4seq1.xml · nonDerivative · entry 1 Maloney James P. · CIK 0001715428 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,853 Read SEC document |
| March 17, 2021 Filed Mar 19, 2021 22:18 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 776 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-039260 · tm2110392d2_4.xml · nonDerivative · entry 1 Maloney James P. · CIK 0001715428 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,968 F1 · shares: Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 21:32 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 1,192 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-085707 · tm2025382d2_4.xml · nonDerivative · entry 1 Maloney James P. · CIK 0001715428 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,192 F1 · shares: Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 22, 2020 Filed Feb 25, 2020 20:26 UTC | FOSTER L B CO FSTR · Entity 5689 | Tax withholdingCommon Stock | 6,581 | $17.57 | $115,628.17 |
DisclosureSEC source: 0001567619-20-004783 · doc1.xml · nonDerivative · entry 4 Maloney James P. · CIK 0001715428 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,964 Read SEC document |
| February 22, 2020 Filed Feb 25, 2020 20:26 UTC | FOSTER L B CO FSTR · Entity 5689 | GrantCommon Stock | 15,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-004783 · doc1.xml · nonDerivative · entry 3 Maloney James P. · CIK 0001715428 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,545 F1 · shares: Represents performance share units which were contingent rights to receive shares of common stock based on the Issuer's performance against certain pre-established financial metrics for the 2017-2019 performance period. Read SEC document |
| February 22, 2020 Filed Feb 25, 2020 20:26 UTC | FOSTER L B CO FSTR · Entity 5689 | Tax withholdingCommon Stock | 349 | $17.57 | $6,131.93 |
DisclosureSEC source: 0001567619-20-004783 · doc1.xml · nonDerivative · entry 2 Maloney James P. · CIK 0001715428 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,468 Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 20:26 UTC | FOSTER L B CO FSTR · Entity 5689 | Tax withholdingCommon Stock | 759 | $17.57 | $13,335.63 |
DisclosureSEC source: 0001567619-20-004783 · doc1.xml · nonDerivative · entry 1 Maloney James P. · CIK 0001715428 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,817 Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 21:35 UTC | FOSTER L B CO FSTR · Entity 5689 | GrantCommon Stock | 5,180 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-004690 · doc1.xml · nonDerivative · entry 1 Maloney James P. · CIK 0001715428 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,576 F1 · shares: Award of time vested restricted stock, which will vest in 33-1/3 increments on each of the first, second and third anniversaries of the date of the grant. Read SEC document |
| September 18, 2019 Filed Sep 20, 2019 15:21 UTC | FOSTER L B CO FSTR · Entity 5689 | Tax withholdingCommon Stock | 388 | $21.90 | $8,497.20 |
DisclosureSEC source: 0001567619-19-018574 · doc1.xml · nonDerivative · entry 1 Maloney James P. · CIK 0001715428 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,396 Read SEC document |
| February 22, 2019 Filed Feb 25, 2019 20:29 UTC | FOSTER L B CO FSTR · Entity 5689 | Tax withholdingCommon Stock | 363 | $17.88 | $6,490.44 |
DisclosureSEC source: 0001567619-19-005339 · doc1.xml · nonDerivative · entry 2 Maloney James P. · CIK 0001715428 · Senior VP, CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,784 Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 20:29 UTC | FOSTER L B CO FSTR · Entity 5689 | GrantCommon Stock | 5,226 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-005339 · doc1.xml · nonDerivative · entry 1 Maloney James P. · CIK 0001715428 · Senior VP, CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,147 F1 · shares: Award of time vested restricted stock, which will vest in 33-1/3% increments on each of the first, second, and third anniversaries of the date of the grant. Read SEC document |
| September 18, 2018 Filed Sep 20, 2018 19:49 UTC | FOSTER L B CO FSTR · Entity 5689 | Tax withholdingCommon Stock | 268 | $22.40 | $6,003.20 |
DisclosureSEC source: 0001567619-18-002931 · doc1.xml · nonDerivative · entry 1 Maloney James P. · CIK 0001715428 · Senior VP, CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,921 Read SEC document |
| February 22, 2018 Filed Feb 26, 2018 20:39 UTC | FOSTER L B CO FSTR · Entity 5689 | GrantCommon Stock | 2,397 | $28.20 | $67,595.40 |
DisclosureSEC source: 0001140361-18-010128 · doc1.xml · nonDerivative · entry 1 Maloney James P. · CIK 0001715428 · Senior VP, CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,189 F1 · shares: Award of time vested restricted stock, which will vest in 33-1/3% increments on each of the first, second, and third anniversaries of the date of the grant. Read SEC document |
| September 18, 2017 Filed Sep 19, 2017 18:17 UTC | FOSTER L B CO FSTR · Entity 5689 | GrantCommon Stock | 2,792 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-035887 · doc1.xml · nonDerivative · entry 1 Maloney James P. · CIK 0001715428 · Senior VP, CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,792 F1 · shares: Award of time vesting restricted stock, which will vest in 33-1/3% increments on each of the first, second, and third anniversaries of the date of the grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.